Thursday, September 22, 2011


I was just informed by my UCLA study representative (we've moved into an extension study) that Otsuka will be using the Riverside Data to present to the FDA successful results in the Tolvaptan Trial. They are hoping for a fast track for the drug since it is currently in use for heart patients.

1 comment:

Anonymous said...

Thanks for the update, Julie. The excessive urination and thirst don't sound like fun but if it works... Hope things continue to work out for you. Happy holidays!